as on October 28, 2025 at 4:01 pm IST
Day's Low
Day's High
1.41%
Downside
0.24%
Upside
52 Week's Low
52 Week's High
33.92%
Downside
15.18%
Upside
as on October 28, 2025 at 4:01 pm IST
Market Cap
₹7,534.15 Cr
Return on Equity (ROE)
14.85
PE Ratio (TTM)
28.27
Return on capital employed (ROCE)
17.33
Industry PE ratio
41.98
Beta (LTM)
1.01
P/B Ratio
3.68
Dividend Yield
0.67
PEG Ratio
6.23
Quarterly Earnings Growth YOY
-10.73
EPS (TTM)
30.06
Sector
Pharmaceuticals
Book Value
219.55
Technical Analysis
Bullish
View Technical Analysis
as on October 28, 2025 at 4:01 pm IST
Aarti Pharmalabs Ltd in the last 5 years
Lowest (11.23x)
February 2, 2023
Today (28.27x)
October 27, 2025
Industry (41.98x)
October 27, 2025
Highest (32.82x)
July 16, 2025
Today’s Price to Earnings Ratio: 28.27x
Compare market cap, revenue, PE, and other key metrics of Aarti Pharmalabs Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 7,534.15 | 37.67% | 0.59 | 272 | 2,115 | |
| BUY | 15,324.72 | 58.42% | 0.51 | 541 | 1,937 | |
| NA | 338.49 | 17.18% | 0.68 | 18 | 344 | |
| NA | 188.76 | 26.01% | 0.50 | 19 | 112 | |
| NA | 25.02 | 2.65% | 0.00 | -2 | 24 |
Search interest for Aarti Pharmalabs Ltd Stock has decreased by -23% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Aarti Pharmalabs Ltd.
Aarti Pharmalabs Ltd’s net profit fell -10.73% since last year same period to ₹49.50Cr in the Q1 2025-2026. On a quarterly growth basis, Aarti Pharmalabs Ltd has generated -43.97% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Aarti Pharmalabs Ltd has declared dividend of ₹2.50 per share on 10 May 2025 - translating a dividend yield of 0.72%.
Read More about DividendsCheck stock indices that include Aarti Pharmalabs Ltd.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
![]()
Retail Investor have increased holdings from 41.12% to 42.13% in Sep 2025 quarter
Price Rise
![]()
In the last 1 year, AARTIPHARM stock has moved up by 31.4%
FII Holding Up
![]()
Foreign Institutions have increased holdings from 7.35% to 8.02% in Sep 2025 quarter
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 562.17 Cr → 387.79 Cr (in ₹), with an average decrease of 31.0% per quarter
Profit Down
![]()
Netprofit is down for the last 2 quarters, 88.34 Cr → 49.5 Cr (in ₹), with an average decrease of 44.0% per quarter
Promoter Holding Down
![]()
Promoters have decreased holdings from 43.72% to 42.88% in Sep 2025 quarter
MF Holding Down
![]()
Mutual Funds have decreased holdings from 0.90% to 0.79% in Sep 2025 quarter
| Organisation | Aarti Pharmalabs Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| CEO | Rashesh C Gogri |
| E-voting on shares | Click here to vote |
Aarti Pharmalabs Ltd share price today stands at ₹843 as on at the close of the market. Aarti Pharmalabs Ltd share today touched a day high of ₹845 and a low of ₹831.15.
Aarti Pharmalabs Ltd touched a 52 week high of ₹971 and a 52 week low of ₹557.05. Aarti Pharmalabs Ltd share price today i.e. is closed at ₹843, which is -13.18% down from its 52 week high and 51.33% up from its 52 week low.
Aarti Pharmalabs Ltd market capitalisation is ₹7,534.15 Cr as on .
To buy Aarti Pharmalabs Ltd shares, you need to follow these steps:
Aarti Pharmalabs Ltd trading volume is 1.04L as on . This means that 1.04L shares of Aarti Pharmalabs Ltd were bought and sold on the stock market during today's trading session.